البحث | SPORTIVO Network

NikitaG أضاف وظيفة جديدة أخرى
2026-01-22 11:27:58

Hematology Analyzer Market Size Projected to Reach USD 9.35 Billion by 2032
“According to a new report published by Introspective Market Research, Hematology Analyzer Market by Product Type, End User, and Modality, The Global Hematology Analyzer Market Size Was Valued at USD 4.92 Billion in 2023 and is Projected to Reach USD 9.35 Billion by 2032, Growing at a CAGR of 7.4%.” The Hematology Analyzer Market plays a critical role in modern diagnostic...

0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
NikitaG أضاف وظيفة جديدة أخرى
2025-12-26 06:55:11

Hematology Market Size Projected to Reach USD 12.1 Billion by 2032
“According to a new report published by Introspective Market Research, Hematology Market by Product, Application, and End-User, the Global Hematology Market Size Was Valued at USD 6.6 Billion in 2023 and is Projected to Reach USD 12.1 Billion by 2032, Growing at a CAGR of 6.1%.” The Hematology Market encompasses diagnostic tests, reagents, and instruments used to study and manage...

0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
shwetakadam أضاف وظيفة جديدة أخرى
2025-10-29 06:09:40

Hematology Oncology Market Insights: Growth, Share, Value, Size, and Trends
"Executive Summary Hematology Oncology Market Market Size and Share: Global Industry Snapshot CAGR Value Data Bridge Market Research analyses that the hematology oncology market which was USD 8.13 billion in 2021, would rocket up to USD 14.83 billion by 2029, and is expected to undergo a CAGR of 7.80% during the forecast period 2022 to 2029. For an actionable market insight and...

0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
rishika_2003 أضاف وظيفة جديدة Health
2026-03-13 09:33:39

Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma Therapies
According to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...

1

0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
rishika_2003 أضاف وظيفة جديدة Health
2026-03-16 12:16:43

Global Romiplostim Market to Reach USD 2.75 Billion by 2034 Driven by Rising ITP Cases
According to a new report from Intel Market Research, the global Romiplostim market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.75 billion by 2034, growing at a steady CAGR of 7.2% during the forecast period (2026-2034). This growth trajectory reflects the rising global burden of chronic immune thrombocytopenia (ITP) and increasing adoption of targeted biologic...

0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Kumud أضاف وظيفة جديدة Health
2026-03-31 11:04:41

GVHD Treatment Market to Reach USD 2.1 Billion by 2031 | CAGR 8.5%
According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031. Graft versus Host Disease, a serious complication following stem cell or bone...

0 التعليقات 0 المشاركات 608 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Kumud أضاف وظيفة جديدة Health
2026-04-06 12:35:59

Rare Hemophilia Factors Market to Reach USD 247 Million by 2031 | CAGR 3.1%
According to a newly published market research report by 24LifeSciences, global rare hemophilia factors market was valued at USD 200 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025-2031. Rare hemophilia factors represent specialized blood-clotting proteins essential for treating...

0 التعليقات 0 المشاركات 75 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Kumud أضاف وظيفة جديدة Health
2026-04-06 12:37:24

Rare Hemophilia Factors Market to Reach USD 247 Million by 2031 | CAGR 3.1%
According to a newly published market research report by 24LifeSciences, global rare hemophilia factors market was valued at USD 200 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025-2031. Rare hemophilia factors represent specialized blood-clotting proteins essential for treating...

0 التعليقات 0 المشاركات 72 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!